National Health Investors (NYSE:NHI - Get Free Report) will likely be issuing its quarterly earnings data after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of $1.10 per share and revenue of $81.13 million for the quarter. Parties that wish to listen to the company's conference call can do so using this link.
National Health Investors Trading Down 1.0 %
NHI stock traded down $0.71 during midday trading on Friday, reaching $69.05. The company's stock had a trading volume of 172,620 shares, compared to its average volume of 190,454. National Health Investors has a 52 week low of $55.99 and a 52 week high of $86.13. The stock has a market cap of $3.14 billion, a PE ratio of 23.73, a price-to-earnings-growth ratio of 4.42 and a beta of 1.06. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The business's 50-day simple moving average is $68.69 and its 200-day simple moving average is $75.14.
Wall Street Analyst Weigh In
Separately, Truist Financial cut their target price on shares of National Health Investors from $78.00 to $72.00 and set a "hold" rating on the stock in a report on Monday, December 23rd. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $76.60.
View Our Latest Stock Analysis on National Health Investors
National Health Investors Company Profile
(
Get Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Articles
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
